We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevalence of Coronary Artery Disease in the Siblings of Premature Coronary Heart Disease

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2012 by Hyuk-Jae Chang, Yonsei University.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00918242
First Posted: June 11, 2009
Last Update Posted: July 23, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Korean Society of Lipidology and Atherosclerosis
Information provided by (Responsible Party):
Hyuk-Jae Chang, Yonsei University
June 10, 2009
June 11, 2009
July 23, 2012
June 2009
September 2012   (Final data collection date for primary outcome measure)
evaluation of prevalence to coronary artery disease using CT [ Time Frame: within 2 weeks from CT scanning ]
Same as current
Complete list of historical versions of study NCT00918242 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Prevalence of Coronary Artery Disease in the Siblings of Premature Coronary Heart Disease
Assessment of Occult CAD: Premature CAD Sibling Study (PreCASS)
The aim of this prospective study is to investigate the prevalence of coronary artery disease using computed tomography with family history of premature coronary heart disease
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
the siblings of premature coronary heart disease (male<55years old, female<65yeasrs old: Framingham Heart Study) patients admitted relevant hospital within 1 year
Coronary Heart Disease
Not Provided
Not Provided
Arad Y, Spadaro LA, Goodman K, Newstein D, Guerci AD. Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol. 2000 Oct;36(4):1253-60.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
87
Not Provided
September 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • within 1 year
  • the siblings of premature coronary heart disease (male<55years old, female<65yeasrs old: Framingham Heart Study) patients admitted relevant hospital

Exclusion Criteria:

  • Documented coronary heart disease
  • experienced adverse events with relevant treatment
  • contraindicated with beta-blockers
  • Any woman of childbearing potential who is pregnant, seeking to become pregnant or suspects
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
 
NCT00918242
20090616
Yes
Not Provided
Not Provided
Hyuk-Jae Chang, Yonsei University
Yonsei University
Korean Society of Lipidology and Atherosclerosis
Principal Investigator: Hyuk-Jae Chang, MD, PhD Cardiology Division, Severance Cardiovascular Hospital, Yonsei University College of Medicine
Yonsei University
July 2012